Fudenberg h hugh (15 Ergebnisse)

Paperback. Zustand: Very Good. Title: Basic and Clinical Immunology This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping.…

Paperback. Zustand: Very Good. This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. …

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,550grams, ISBN:0306412314. …

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Postkarte. Zustand: Gut. Sonderdruck-Anforderungs-Postkarte von H. Hugh Fudenberg an Herbert Tichy vom Max-Planck-Institut für Biologie zu Tübingen vom 3. Januar 1967 - maschinenschriftlich ausgefüllt und unsigniert /// Autogramm Autograph signiert signed signee /// Herman Hugh Fudenberg (October 24, 1928 - March 15, 2014) was an American clinical immunologist and founder of the NeuroImmuno Therapeutics Research Foundation (NITRF). Biography He received his A.B. from UCLA in 1949 and his MD from the University of Chicago in 1953.[1] Fudenberg received his M.A. in immunochemistry from Boston University in 1957.[2] The areas of his research, conducted primarily in the 1960s and 1970s, included research into immunoglobulin and receptors for this molecule in human monocytes,[3] as well as the ability of red blood cells to, in vitro, form "rosette" formations around peripheral blood lymphocytes.[4] Fudenberg was hired by the Special Projects Unit of the Council for Tobacco Research in 1972, to study whether some people are genetically predisposed to emphysema. He initially found that up to 10% might be, and was planning on warning such people not to smoke tobacco, but his funding was cut off without explanation before he could do so. "They may have cut me off because it would have been negative for them," Fudenberg suggested.[5] He trained from 1954 to 1956 under William Dameshek, former editor of Blood and completed a residency at Peter Bent Brigham Hospital from 1956 to 1958.[6] Fudenberg was a professor of medicine for 15 years (first associate, and later full) at University of California, San Francisco, as well as associate professor of immunology at the University of California, Berkeley. He was editor of the journal Clinical Immunology and Immunopathology for 15 years and developed the Rosette test as well.[7] Additionally, Fudenberg sat on the World Health Organization's expert committee on immunology for 20 years.[8] In 1974, he relocated to South Carolina, specifically the Medical University of South Carolina, where he remained as a professor until 1989. Fudenberg was a proponent of the discredited hypothesis that there was a connection between the MMR vaccine and autism. In 1995 Fudenberg's medical license was suspended for improperly obtaining controlled substances. MMR vaccine and autism Further information: MMR vaccine and autism In the 1980s Fudenberg began claiming that the MMR vaccine causes autism. The scientific consensus says that no evidence links the vaccine to the development of autism and that the vaccine's benefits greatly outweigh its risks.[9] Fudenberg published his research in the fringe journal Biotherapy (now discontinued) in 1996, concluding that "Fifteen of the [True Autism] patients developed symptoms within a week after immunization with the [MMR] vaccine";[10] further asserting that "Fudenberg healed children, with a quarter 'fully normalised'."[10] This paper was cited by Andrew Wakefield's fraudulent 1998 Lancet paper.[11] The proposal of a vaccine-autism link has been called "the most damaging medical hoax of the last 100 years".[9] Fudenberg claimed in a 2004 interview with Brian Deer that he was able to cure autistic children using his own bone marrow.[12] Fudenberg was a co-inventor of the autism "treatments" Wakefield obtained a patent for in 1997,[13] and Wakefield stated the same year in a letter to the bursary of Royal Free Hospital's School of Medicine that he was waiting on a business plan from NITRF.[14] Flu vaccine claims In a 2005 episode of Larry King Live in which Bill Maher was being interviewed by Larry King, Maher argued that "if you have a flu shot for more than five years in a row, there's ten times the likelihood that you'll get Alzheimer's disease."[15] This claim has been traced by David Gorski back to Fudenberg; Gorski noted that it appeared on what he called an "über-crank" website.[16] Specifically, it appears Fudenberg made the claim when speaking at the 1st annual International Public Conference on Vaccination, held by the National Vaccine Information Center in Arlington, Virginia in 1997.[17] The origin of the claim is unknown, as there is no study published in a peer-reviewed journal making such a claim. Furthermore, one study found that past exposure to influenza vaccines is associated with lower risk for Alzheimer's disease.[18] License revocation In 1995 Fudenberg's medical license was revoked. The Casewatch website states: "the South Carolina medical board found Fudenberg "guilty of engaging in dishonorable, unethical, or unprofessional conduct," fined him $10,000, ordered him to surrender his license to prescribe controlled substances (narcotic drugs), and placed his license on indefinite suspension."[19] The board found that: The Respondent admitted that he has on numerous occasions obtained controlled substances and legend drugs, namely, prosom, ambien, lasix, and potassium from a member of his office staff and others, and that he has unlawfully obtained these controlled substances for his own use, and has, in fact, used these medications.[19] In an interview with The Post and Courier, Fudenberg contended that "alcohol and opiate charges are completely false" and tried to attribute many of the problems to a former staff member at NITRF. Death On March 15, 2014, Fudenberg died at the age of 85. He was survived by his four sons, including economist Drew Fudenberg.[20] /// Standort Wimregal GAD-30.213 WITHIN THE EU: shipping only to GERMANY and AUSTRIA due to the new EPR regulations. Sprache: Englisch Gewicht in Gramm: 10.…

Second edition. 8vo. ix, 262 pp. Photos, figs., index. Pictorial wrappers. FINE.

Zustand: New. In.

Zustand: New. In.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ('monoclonal antibodies') have already pro vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal,S 6 8 Business Week, Fortune,7 and The Economist, as well as in such stock 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as impor tant to biomedical scientists in keeping abreast of new scientific devel opments in biotechnology as is Current Contents. (The costs of health cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro kers increasingly no longer confine their reading to economic journals but are also perusing Nature,ll Science,12 and Science N 13 for infor ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g. , ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - On May 14-16, 1982, a group of scientists met in Viareggio, Italy to present ideas, and exchange relevant data on current approaches on immunomodulators. We felt that the embodiment of the substance of that international symposium into this volume will be beneficial in keeping both clinicians and basic scientists abreast of the latest exciting developments in this rapidly accelerating field. We hope that the publication of this series of papers by an international panel of experts will enhance the nature of future inves t igat ive stud ies with such ent it ies . Under the rubric of immunology, it is obvious that such a term as 'immunomodulation' could be construed as being all encompassing. However, it is intriguing that the immune modulators touched on in these sessions can be subcategorized into about five broad groups. Almost all substances, excepting those entities that are immuno logically inert, will have some modulating effects on immunity. From the coarse adjustment of antibody feedback inhibition upon cellular limnunity to the subtle finesse envisioned in Jerne's idiotypic network and s'lppressor T cells, immunomodulators attempt to either magnify or diminish those responses that are normally elicited by antigen. The broad groups - thymic hormones, D.L.E., Interferon, drugs, and the use of bacterial products appear to be at the forefront of much of the pioneering work on immunomodulation.…

Paperback. Zustand: Brand New. 468 pages. 9.61x6.69x1.07 inches. In Stock.

Zustand: New.

Zustand: Very Good. Very Good condition. 3rd edition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp.

New York, Oxford University Press, 1972, 8°, VIII, (2), 214 pp., orig. kartonierter Einband; auf Vorsatz mit eigenhändigen Widumungen von Daniel P.Sites und An-Chuan Wang.

Zeitschrift 17x24. Zustand: Gut. 122 Seiten altersbedingt Zustand Einband abgegriffen und mit Zahlen beschrieben 200635819 Sprache: Deutsch Gewicht in Gramm: 300.